remibrutinib
novartis
['remibrutinib', '#1113']
phase 2 study 24 weeks of #remibrutinib - lou064 - in patients with #sj grens primary outcome met however look at the esspri trajectory #1113 #acr22 
MD PhD? Clinician in Internal Medicine and Rheumatology ? Clinical and translational Researcher  ? @ARD_BMJ ? @oegrr ? @EULAR_JC